Suku brings more than 25 years of experience in gene therapy development, clinical development strategy, medical affairs, diagnostics, payer strategy and commercialization of therapeutic products; also currently advising many other gene therapy and healthcare companies.

Formerly of AveXis, Quest Diagnostics and Pfizer.